The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1735-2023·Announced 2023-06-28

Implantable defibrillators risk energy output failure during high voltage therapy

Certain Medtronic cardiac defibrillators may produce reduced or no energy output during high voltage therapy. The defect involves a specific feedthrough component used in the manufacturing process.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I classification mandates a minimum severity score of 4. The potential for reduced or no energy output during therapy in an implantable defibrillator constitutes a serious health risk that could prevent treatment of life-threatening cardiac arrhythmias.

Plain-English summary

Medtronic is recalling certain CRT-D VIVA XT implantable defibrillators due to a rare potential for reduced or no energy output during high voltage therapy, typically at energy levels of 0-12 joules. The issue affects devices manufactured with a specific feedthrough type and has been identified in currently available models distributed nationwide and worldwide.

The recalled devices may fail to deliver adequate electrical energy during defibrillation therapy, which could prevent the device from properly treating life-threatening cardiac arrhythmias. This defect applies to devices already implanted and currently in use in patients.

Patients with potentially affected devices should contact their healthcare provider or Medtronic for information about their specific device model and any necessary actions. Patients should work with their medical team to determine if their device is part of this recall and to discuss appropriate management options.

The recalled product

Product
CRT-D DTBA2D1 VIVA XT IS1/DF1 INTL, Model Number DTBA2D1; Implantable Cardioverter Defibrillators
Affected units
4,354

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (20)

  • GTIN 00643169217959
  • Lot Serial Numbers: BLJ622286S
  • BLJ622571S
  • BLJ622623S
  • BLJ622733S
  • BLJ622742S
  • BLJ622966S
  • BLJ624144S
  • BLJ622126S
  • BLJ624009S
  • BLJ622569S
  • BLJ623322S
  • BLJ622064S
  • BLJ622092S
  • BLJ623468S
  • BLJ623621S
  • BLJ623849S
  • BLJ624135S
  • BLJ622023S
  • BLJ623580S

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 120 products in this recall →

Similar recalls